Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation
(NASDAQ: ABVX) Delayed: 101.66 +2.51 (2.53%)
Previous Close $99.15    52 Week High $ 
Open $99.10    52 Week Low $ 
Day High $103.83    P/E N/A 
Day Low $97.50    EPS $ 
Volume 2,237,680       

(NASDAQ: ORKA) Delayed: 85.38 +13.04 (18.03%)
Previous Close $72.34    52 Week High $ 
Open $81.00    52 Week Low $ 
Day High $88.83    P/E N/A 
Day Low $79.00    EPS $ 
Volume 4,201,124       

(NASDAQ: SYRE) Delayed: 100.32 +11.98 (13.56%)
Previous Close $88.34    52 Week High $ 
Open $95.00    52 Week Low $ 
Day High $101.71    P/E N/A 
Day Low $95.00    EPS $ 
Volume 2,804,957